Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 168,229 | 82,548 | 48,344 | 25,705 |
| Receivables | N/A | N/A | 333 | 1,495 |
| TOTAL | $169,337 | $85,391 | $49,220 | $27,684 |
| Non-Current Assets | ||||
| PPE Net | 2,666 | 1,106 | 1,173 | 1,060 |
| Other Non-Current Assets | 5,539 | 131 | 461 | 50 |
| TOTAL | $8,205 | $1,237 | $1,634 | $1,110 |
| Total Assets | $177,542 | $86,628 | $50,854 | $28,794 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,579 | 1,074 | 1,606 | 600 |
| Accrued Expenses | 8,429 | 4,536 | 3,954 | 1,210 |
| TOTAL | $10,008 | $5,610 | $5,560 | $1,810 |
| Non-Current Liabilities | ||||
| Long Term Debt | 10,254 | 9,861 | 9,465 | N/A |
| Other Non-Current Liabilities | 5,820 | 1,352 | 2,000 | 1,299 |
| TOTAL | $16,074 | $11,213 | $11,465 | $1,299 |
| Total Liabilities | $26,082 | $16,823 | $17,025 | $3,109 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 27,072 | N/A | N/A | N/A |
| Common Shares | 3 | N/A | N/A | N/A |
| Retained earnings | -138,396 | -76,965 | -40,660 | -12,950 |
| Other shareholders' equity | -101 | 141,398 | -46 | -22 |
| TOTAL | $151,460 | $69,805 | $33,829 | $25,685 |
| Total Liabilities And Equity | $177,542 | $86,628 | $50,854 | $28,794 |